Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00578162
Other study ID # 05-048
Secondary ID
Status Completed
Phase N/A
First received December 19, 2007
Last updated January 6, 2012
Start date April 2005
Est. completion date April 2009

Study information

Verified date January 2012
Source Memorial Sloan Kettering Cancer Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

To describe the range of services available to cancer survivors in the NYC area.

To determine organizations' need for assistance to enhance services for survivors.


Description:

To describe the range of services available to cancer survivors in the NYC area.

To determine organizations' need for assistance to enhance services for survivors.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date April 2009
Est. primary completion date April 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- To be eligible to participate in the study, an agency must:

1. Be a current provider of either:

- General health services (GHS), such as primary care, health education and wellness, mental health services, home health care, palliative care, or cancer screening and diagnosis;

- Cancer-specific medical treatments (CMT), such as cancer surgery, radiation, chemotherapy, hormonal therapy; experimental therapies; cancer pain and symptom management; rehabilitation services; post-treatment monitoring and surveillance; or prophylactic treatments, such as chemoprevention; or

- Any type of specialized 'post-cancer' or 'after-cancer' medical care or support services (SMC) (i.e., psychotherapeutic, relationship and family, psycho-educational,wellness and quality of life)

2. Be located within the five boroughs of New York City

3. Have been serving cancer patients for 12 months or longer, and

4. Be willing and able to identify an English-speaking representative, 21 years of age or older as its designated key informant.

Exclusion Criteria:

- We will limit this study to provider agencies such as hospitals, diagnostic centers, clinics, health and human service agencies, and grassroots community organizations and public service settings that offer programs for cancer survivors. Independent practitioners or private practice settings will not be surveyed. Our survey questions are intended for major health services organizations and are not appropriate for private practices settings.

We will use our screening questionnaire to determine where or not a given agency should be included or excluded from the study AGENCY SCREENER.

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Behavioral:
we will screen potential agencies using our CALL SCRIPT and our AGENCY SCREENER
A cancer care facility or 'agency' is the study's unit of analysis. Data about participating agencies will be collected by electronic survey. Agencies will be identified using the NYSDOH's existing mailing list of care facilities located in the five boroughs of New York City, referral databases and resource guides created by the American Cancer Society (ACS), the New York Hospital Directory

Locations

Country Name City State
United States Memorial Sloan-Kettering Cancer Center New York New York

Sponsors (2)

Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center NYS DEPT HEALTH CANCER SVC PRO

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine agencies' need for assistance to enhance services for survivors. 2 years No
See also
  Status Clinical Trial Phase
Completed NCT04316962 - Cancer Rehabilitation in Primary Health Care N/A